Back

Hypothetical Human Immune Genome Complex Gradient May Help To Explain The Congenital Zika Symdrome Catastrophe In Brazil: A New Theory

Oliveira, F.; Bresani-Salvi, C.; Morais, C.; Bigham, A.; Braga-Neto, U.; Maestre, G.; Vandebergh, J. L.; Marques, E.; Acioli-Santos, B.

2020-06-04 genetics
10.1101/2020.06.03.132878 bioRxiv
Show abstract

There are few data considering human genetics as an important risk factor for birth abnormalities related to ZIKV infection during pregnancy, even though sub-Saharan African populations are apparently more resistant to CZS as compared to populations in the Americas. We hypothesized that single nucleotide variants (SNVs), especially in innate immune genes, could make some populations more susceptible to Zika congenital complications than others. Differences in the SNV frequencies among continental populations provide great potential for Machine Learning techniques. We explored a key immune genomic gradient between individuals from Africa, Asia and Latin America, working with complex signatures, using 297 SNVs. We employed a two-step approach. In the first step, decision trees (DTs) were used to extract the most discriminating SNVs among populations. In the second step, machine learning algorithms were used to evaluate the quality of the SNV pool identified in step one for discriminating between individuals from sub-Saharan African and Latin-American populations. Our results suggest that 10 SNVs from 10 genes (CLEC4M, CD58, OAS2, CD80, VEPH1, CTLA4, CD274, CD209, PLAAT4, CREB3L1) were able to discriminate sub-Saharan Africans from Latin American populations using only immune genome data, with an accuracy close to 100%. Moreover, we found that these SNVs form a genome gradient across the three main continental populations. These SNVs are important elements of the innate immune system and in the response against viruses. Our data support the Human Immune Genome Complex Gradient hypothesis as a new theory that may help to explain the CZS catastrophe in Brazil.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Frontiers in Genetics
197 papers in training set
Top 0.1%
28.6%
2
PLOS ONE
4510 papers in training set
Top 12%
14.9%
3
Scientific Reports
3102 papers in training set
Top 13%
7.1%
50% of probability mass above
4
Infection, Genetics and Evolution
43 papers in training set
Top 0.1%
4.1%
5
Biology
43 papers in training set
Top 0.1%
4.1%
6
Genes
126 papers in training set
Top 0.4%
2.7%
7
PLOS Computational Biology
1633 papers in training set
Top 13%
2.4%
8
Gene
41 papers in training set
Top 0.5%
2.1%
9
Gene Reports
13 papers in training set
Top 0.3%
1.8%
10
Frontiers in Immunology
586 papers in training set
Top 4%
1.8%
11
PeerJ
261 papers in training set
Top 8%
1.5%
12
European Journal of Human Genetics
49 papers in training set
Top 0.7%
1.4%
13
Journal of Medical Virology
137 papers in training set
Top 3%
1.3%
14
Archives of Clinical and Biomedical Research
28 papers in training set
Top 1%
1.3%
15
Virus Research
36 papers in training set
Top 0.8%
1.1%
16
Genes & Immunity
11 papers in training set
Top 0.1%
1.1%
17
Journal of Virology
456 papers in training set
Top 3%
0.9%
18
Frontiers in Medicine
113 papers in training set
Top 5%
0.9%
19
Briefings in Bioinformatics
326 papers in training set
Top 6%
0.8%
20
BioMed Research International
25 papers in training set
Top 3%
0.8%
21
BMC Medical Genomics
36 papers in training set
Top 1%
0.8%
22
Heliyon
146 papers in training set
Top 6%
0.8%
23
Genetics Selection Evolution
33 papers in training set
Top 0.2%
0.8%
24
Informatics in Medicine Unlocked
21 papers in training set
Top 1%
0.7%
25
Viruses
318 papers in training set
Top 5%
0.7%
26
BMC Bioinformatics
383 papers in training set
Top 7%
0.7%
27
Computers in Biology and Medicine
120 papers in training set
Top 5%
0.7%
28
Molecular Genetics and Genomics
11 papers in training set
Top 0.4%
0.7%
29
PLOS Neglected Tropical Diseases
378 papers in training set
Top 6%
0.7%
30
Diagnostic Microbiology and Infectious Disease
21 papers in training set
Top 0.3%
0.7%